个性化文献订阅>期刊> Journal of Medicinal Chemistry
 

Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-beta(3)-pseudopeptide Agonist

  作者 NEVEU CINDY; LEFRANC BENJAMIN; TASSEAU OLIVIER; DOREGO JEANCLAUDE; BOURMAUD ADELE; CHAN PHILIPPE; BAUCHAT PATRICK; LE MAREC OLIVIER; CHUQUET JULIEN; GUILHAUDIS LAURE; BOUTIN JEAN A; SEGALASMILAZZO ISABELLE; COSTENTIN JEAN; VAUDRY HUBERT; BAUDYFOCH MICHELE; VAUDRY DAVID; LEPRINCE JEROME  
  选自 期刊  Journal of Medicinal Chemistry;  卷期  2012年55-17;  页码  7516-7524  
  关联知识点  
 

[摘要]26RFa, a novel RFamide neuropeptide, is the endogenous ligand of the former orphan receptor GPR103. Intracerebroventricular injection of 26RFa and its C-terminal heptapeptide, 26RFa((20-26)), stimulates food intake in rodents. To develop potent, stable ligands of GPR103 with low molecular weight, we have designed a series of aza-beta(3)-containing 26RFa((20-26)) analogues for their propensity to establish intramolecular hydrogen bonds, and we have evaluated their ability to increase [Ca2+](i) in GPR103-transfected cells. We have identified a compound, [Cmpi(21),aza-beta(3)-Hht(23)]26RFa((21-26)), which was 8-fold more potent than 26RFa((20-26)) in mobilizing [Ca2+](i). This pseudopeptide was more stable in serum than 26RFa((20-26)) and exerted a longer lasting orexigenic effect in mice. This study constitutes an important step toward the development of 26RFa analogues that could prove useful for the treatment of feeding disorders.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内